German drug company Bayer bids $62B for U.S. agriculture firm Monsanto - Action News
Home WebMail Tuesday, November 26, 2024, 06:16 PM | Calgary | -5.3°C | Regions Advertise Login | Our platform is in maintenance mode. Some URLs may not be available. |
Business

German drug company Bayer bids $62B for U.S. agriculture firm Monsanto

German drug and chemicals company Bayer AG announced Monday that it has made a $62 billion offer to buy U.S.-based crops and seeds specialist Monsanto.

Bayer said it plans to finance the acquisition with a combination of debt and equity

The merger would create one of the world's largest chemical companies. ((Dan Gill/Associated Press))

German drug and chemicals company Bayer AG announced Monday that it has made a $62 billion offer to buy U.S.-based crops and seeds specialist Monsanto.

The proposed combination would create a giant seed and farm chemical company with a strong presence in the U.S., Europe and Asia.

Bayer said the all-cash offer values shares of Monsanto at $122 each. That compares with a closing price Friday of $101.52 and is 37 per cent higher than the closing price of $89.03 on May 9, the day before Bayer made a written proposal to Monsanto.

Bayer had said on Thursday that its executives met recently with their Monsanto counterparts "to privately discuss a negotiated acquisition" of the specialist in genetically modified crop seeds, which is headquartered in St. Louis, Missouri. Monsanto said then that it was reviewing Bayer's proposal.

Debt and shares will finance deal

Bayer said it plans to finance the acquisition with a combination of debt and equity, the latter to be raised largely by issuing new shares. Bayer's shares, which tumbled after the initial announcement last week, dropped 3.1 per cent in early Frankfurt trading Monday to 86.78 euros. Monsanto shares jumped 11.3 per cent to $112.98 in New York.

The German company said that it "is prepared to proceed immediately to due diligence and negotiations and to quickly agree to a transaction."

"Monsanto is a perfect match to our agricultural business," Bayer CEO Werner Baumann said in a video message posted on his company's website. "We would combine complementary skills with minimal geographic overlap."

"The acquisition of Monsanto checks all the boxes in terms of strategic fit and value creation potential," he added. "At the same time, ongoing consolidation activities in the industry make this combination by far the most attractive one."

Baumann said Bayer expects the transaction to "create significant synergies" and bolster earnings in the first full year after it is completed.

Both companies are familiar brands on farms around the globe. Bayer's farm business produces seeds as well as compounds to kill weeds, bugs and fungus.

Monsanto has some 20,000 employees and produces seeds for fruits, vegetables and other crops including corn, soybeans and cotton, as well as the popular weed-killer Roundup.

Bayer, headquartered in Leverkusen, Germany, employs some 117,000 people worldwide.